Saikosaponin C is widely studied for its anti-inflammatory and immunomodulatory properties. It has shown potential in suppressing pro-inflammatory cytokines, making it a candidate for research in autoimmune and chronic inflammatory diseases. It also exhibits hepatoprotective effects, supporting liver health by reducing liver enzyme levels and protecting against liver damage caused by toxins or viral infections. In cancer research, Saikosaponin C demonstrates anti-proliferative activity against various tumor cell lines, including lung, liver, and breast cancer cells, by inducing apoptosis and inhibiting cell cycle progression. It may also enhance the efficacy of conventional chemotherapy drugs. Additionally, it has been investigated for antiviral activity, particularly against hepatitis B and C viruses, due to its ability to interfere with viral replication. Its neuroprotective effects are being explored in neurodegenerative conditions, where it may help reduce neuronal inflammation and oxidative stress. Due to these diverse biological activities, Saikosaponin C is a key focus in the development of herbal-based therapeutics, especially in traditional medicine formulations aimed at liver support, immune regulation, and cancer adjuvant therapy.